Поиск по каталогу |
(строгое соответствие)
|
- Профессиональная
- Научно-популярная
- Художественная
- Публицистика
- Детская
- Искусство
- Хобби, семья, дом
- Спорт
- Путеводители
- Блокноты, тетради, открытки
Parallel Trade Restraints in Pharmaceuticals and EU Competition Rules.
В наличии
Местонахождение: Алматы | Состояние экземпляра: новый |
Бумажная
версия
версия
Автор: Megi Medzmariashvili
ISBN: 9783639718577
Год издания: 2018
Формат книги: 60×90/16 (145×215 мм)
Количество страниц: 68
Издательство: Scholars' Press
Цена: 26397 тг
Положить в корзину
Способы доставки в город Алматы * комплектация (срок до отгрузки) не более 2 рабочих дней |
Самовывоз из города Алматы (пункты самовывоза партнёра CDEK) |
Курьерская доставка CDEK из города Москва |
Доставка Почтой России из города Москва |
Аннотация: The European Union protects parallel trade as one of the foundations of the Union. Although the pharmaceutical sector is more sensitive to parallel trade, no distinction is made for this specific industry. Thus, this book tries to cover parallel trade issues in pharmaceutical industry and assess whether there is room for justified restrictions of parallel trade within EU competition rules. A conclusion is drawn, that the EU Courts are cautions to accept different treatment of the pharmaceutical sector. However, it is suggested that the EU Courts would open doors for the justification of restrictions on parallel trade, but only if a direct link between parallel trade and loss in long-run dynamic efficiency is proven by a pharmaceutical company. Furthermore, this will be done only on a case by case basis in order to not sacrifice the goal of achieving an internal market, where the competition rules play an important role. In the light of this conclusion, pharmaceutical companies when thinking of minimizing the risks of competition concerns are advised to consider the important trends and aspects of EU case-law.
Ключевые слова: Competition Law, EU Law, Internal Market, Pharmaceutical Sector